SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-24-000084
Filing Date
2024-05-03
Accepted
2024-05-03 08:42:47
Documents
1
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1714740158.html 4  
1 FORM 4 wk-form4_1714740158.xml 4 6064
  Complete submission text file 0001479290-24-000084.txt   7544
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LEVI STRAUSS & CO. 1155 BATTERY STREET SAN FRANCISCO CA 94111
Business Address
Beraud Jill (Reporting) CIK: 0001520061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 24910934